Lataa...
SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
INTRODUCTION Teriparatide is a recombinant endogenous parathyroid hormone. It is an anabolic medication which is FDA approved for treating Osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis and Glucocorticoid-induced osteoporosis. Transient hypercalcemia with Teripara...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Endocrine Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552103/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-505 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|